Home
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
Spotlight
GLP-1s
Interviews
FDA
Strategy
Generics
Biosimilars
Value Added Medicines
Business
Deals
Earnings
Manufacturing
Policy & Regulation
Regulatory Landscape
Drug Pricing
IP & Litigation
Tools & Trackers
What's Next?
Who's Hired?
UK Pricing Tracker
Company Rankings
Podcasts
Conference Coverage
Partner Insights
Generics Bulletin Perspectives
Exploring market-shifting topics for the off-patent sector.
View
Pink Sheet
Scrip
Medtech Insight
HBW Insight
Generics Bulletin
In Vivo
EMA Panexcell Review Leads Tillomed To Pull Doxorubicin
Follows Major GCP Issues Identified At CRO Panexcell’s Site
Apr 01 2020
•
By
Dean Rudge
The EMA is reviewing studies performed at Panexcell’s site in Mumbai, India • Source: Shutterstock
More from Generics
More from Products